Rocket Pharmaceuticals Total Current Liabilities

Rocket Pharmaceuticals (RCKT) currently reports a total current liabilities of $24M as of March 2026. That compares with $35M in the prior-year period — down 30.7% year over year. Use the charts on this page to explore Rocket Pharmaceuticals's total current liabilities history and peer comparisons.

Rocket Pharmaceuticals's total current liabilities decreased from $35M to $24M — a 30.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rocket Pharmaceuticals reported $24M in total current liabilities as of March 2026. That compares with $35M in the prior-year period — down 30.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $24M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rocket Pharmaceuticals, and consider following RCKT for alerts when major investors trade the stock.

Rocket Pharmaceuticals is classified in the Healthcare sector. On total current liabilities, it currently shows $24M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RCKT with unrelated industries.